NCT06481696View on ClinicalTrials.gov

Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Unexplained Infertility
Interventions
DIETARY_SUPPLEMENT

Resveratrol-based multivitamin supplement

Natural polyphenol and vitamins

DIETARY_SUPPLEMENT

Folic acid

Supplementation with folic acid at the standard dosage of 0.4 mg/die

PROCEDURE

IVF/ICSI

In vitro fertilization/IntraCytoplasmic Sperm Injection

DRUG

Follitropin Alfa

Controlled Ovarian Stimulation

DRUG

Ganirelix Acetate 0.5 MG/ML [Fyremadel]

GnRH Antagonist

DRUG

hCG 10.000 IU or triptorelin 0,3 mg, subcutaneously

For the induction of oocyte maturation

Trial Locations (1)

90144

RECRUITING

ANDROS Day Surgery Clinic, Palermo

All Listed Sponsors
lead

Andros Day Surgery Clinic

OTHER